Dr. Qiao has over 15 years of experience as an entrepreneur and senior manager in the life sciences, finance, and technology industries. Prior to joining Ambrx, he was a partner at Coentre LLC, a private angel investment firm from 2012 to 2015. Before Coentre, he co-founded and was CEO of NNCrystal from 2009 to 2012. NNCrystal is a life sciences and alternative energy technology company with U.S. and China operations, and is now a publicly traded company in China. He was also CEO of NN-Labs, which developed nanomaterials for the life sciences industry from 2008 to 2010 and co-founded and was president of G3 Technology Innovations, which developed nanomaterials for the contract textile industry from 2006 to 2009. Prior to his entrepreneurial career, Dr. Qiao worked at Eastman Kodak Company’s Health Group (now Carestream Health) from 1997 to 2006, where he conceived and oversaw the development of biochips, rare cell separation, and molecular imaging platforms. A prolific inventor with 26 issued U.S. patents, Dr. Qiao earned his Ph.D. in chemistry from the University of Rochester, and completed his postdoctoral training in biochemistry at the Massachusetts Institute of Technology.